Here, using data from TCGA, we found that RRM2B-amplified tumors not only exhibit increased RRM2B expression in multiple cancers (such as breast, ovarian, head, and neck cancer), but also exhibit distinct mutation signatures. This evidence concerns the gene RRM2B and cancer.